--------------------------------
                                                         OMB Approval
                                                --------------------------------
                                                   OMB Number: 3235-0060
                                                   Expires: April 30, 2009
                                                   Estimated average burden
                                                   hours per response.....38.0
                                                --------------------------------



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported):   September 20, 2006
                                                  ------------------------------

                              POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         Minnesota                    0-944                 41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction       (Commission            (IRS Employer
     Identification No.)           File Number)          of incorporation)


9055 Evergreen Boulevard NW, Minneapolis, MN               55433-8003
- --------------------------------------------------------------------------------
(Address of principal executive offices)                   (Zip Code)


Registrant's telephone number, including area code   763-780-4555
                                                   -----------------------------

                                 Not Applicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))




Section 9 - Financial Statements and Exhibits

Item 9.01  Possis Medical Inc. Reports Quarterly Financial and Full-Year Results

On September 20, 2006, the Company issued a press release reporting
operating results for its fiscal year 2006 fourth quarter ending July
31, 2006 and full year results. A copy of the press release is filed
herewith as Exhibit 99.1 to this Report and is incorporated herein by
reference.

[c]    Exhibits.

99.1  Press Release, dated September 20, 2006, issued by Possis Medical, Inc.





                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Possis Medical, Inc.
- --------------------
(Registrant)


Date: September 20, 2006
      ------------------


By: /s/ Jules L. Fisher
    ---------------------------------------------------
        Jules L. Fisher
        Vice President, Finance and Chief Financial Officer





                      EXHIBIT INDEX


Exhibit No.      Description
- -----------      -----------

99.1             Press Release, dated September 20, 2006, issued by Possis
                 Medical, Inc.